ESRD Medical Necessity and Documentation Audit: Orders, Treatment Records, and Drug Billing

A documentation guide for dialysis facilities: physician orders and dialysis prescriptions, treatment flow sheets, extra treatments, ESA and iron billing, anemia monitoring, outlier and TDAPA drugs, phosphate binders, consolidated billing and the AY modifier, home dialysis records, and audit response.

KNOWLEDGE CENTER

11/15/202611 min read

Dialysis is a life-sustaining treatment, and few auditors question whether patients with ESRD need dialysis. Instead, ESRD medical review focuses on whether each billed treatment, drug, and service was ordered, furnished, documented, and billed correctly. Under the bundled ESRD Prospective Payment System (PPS), documentation determines not only whether the facility is paid for a treatment, but also whether adjustments, outlier payments, and drug add-ons are supported.

OIG's provider compliance audits of dialysis facilities have found treatments that were not completed or documented, incomplete assessments and plans of care, height and weight errors, and missing physician progress notes. OIG's ongoing audit of home dialysis services follows prior findings of claims without treatment notes or documentation of dispensed medication.

This article focuses on the documentation that supports ESRD claims: orders, treatment records, and drug billing. It is educational and does not replace legal or professional advice.

Orders and the Dialysis Prescription

Why Orders Matter

Dialysis services must be ordered by a physician or other qualified practitioner. The dialysis prescription specifies the modality, frequency, duration, dialyzer, blood and dialysate flow rates, dialysate composition, target weight, anticoagulation, and vascular access. Drugs administered during dialysis, such as erythropoiesis-stimulating agents (ESAs), iron, and vitamin D analogs, must also be ordered.

Order Documentation

• Signed and dated orders for dialysis, including the complete prescription.

• Orders for each drug, with dose, route, frequency, and indication.

• Standing orders and protocols that are signed, dated, and periodically reviewed by the physician.

• Order changes documented with dates and signatures.

Common Order Errors

• Treatments furnished without a current signed prescription.

• Drugs administered under protocols that were not signed or not current.

• Verbal orders not authenticated within required time frames.

• Orders that do not match what was administered.

Treatment Records

The Treatment Flow Sheet

Each hemodialysis treatment should be documented on a flow sheet or electronic record that includes:

• Date, start time, and end time.

• Pre- and post-treatment weight, vital signs, and assessment.

• Machine settings and dialysis parameters.

• Vascular access assessment.

• Intradialytic monitoring at regular intervals.

• Drugs administered, with dose, time, and staff initials.

• Complications and interventions.

• Reason for any shortened treatment.

• Staff signatures.

Incomplete and Missed Treatments

Medicare pays for treatments furnished. When a treatment is started but not completed, facilities should follow Medicare billing instructions and document the reason. Missed treatments should not be billed. OIG's audits cited treatments that were not completed and services that were not documented as noncompliant.

Treatment Frequency and Medical Justification

Medicare generally pays for three hemodialysis treatments per week. Additional treatments require documented medical justification, such as fluid overload, hyperkalemia, or other clinical conditions. The physician should document the medical reason in the record, and the claim should reflect Medicare billing requirements for additional treatments.

Home Dialysis Records

For home hemodialysis and peritoneal dialysis, facilities must maintain records of training, home treatment logs, supplies and drugs dispensed, monthly assessments, and communications with patients. OIG's DCI audit recommended correcting weight measurement timing for home dialysis patients, and the ongoing home dialysis audit is focused on documentation of treatments and dispensed medication.

Height and Weight

Patient-level payment adjustments for body surface area and body mass index depend on height and weight. CMS instructions specify how and when to measure and report these values on claims, including using post-dialysis weight measurements. OIG found height and weight measurements that did not comply with Medicare requirements in its DCI audit. Facilities should follow CMS instructions and document measurements consistently.

Drug Billing

Drugs Included in the Bundle

Under the ESRD PPS, ESRD-related drugs and biologicals, whether injectable or oral equivalents, are included in the bundled payment. Facilities must report drugs on claims, which supports monitoring, outlier calculations, and TDAPA payments.

ESAs and Anemia Management

ESAs, such as epoetin alfa and darbepoetin alfa, are commonly used to manage anemia. Medicare requires facilities to report hemoglobin or hematocrit values on claims and to follow ESA claims monitoring policies, which use modifiers to indicate when hemoglobin or hematocrit levels exceed thresholds and whether doses were reduced. Documentation should include lab values, dosing decisions, and protocol adherence. FDA labeling for ESAs includes safety warnings about higher hemoglobin targets, and documentation should show individualized dosing.

Iron and Vitamin D

Iron products and vitamin D analogs are included in the bundle and must be ordered and documented. Administration records should match claims.

Outlier Drugs

Outlier payments depend on the imputed cost of ESRD outlier services reported on the claim. Overreporting drug units or reporting drugs that were not administered can inflate outlier payments. Facilities should reconcile drug administration records, inventory, and claims.

TDAPA and Post-TDAPA Drugs

New drugs receiving TDAPA must be billed with required information. CMS also pays post-TDAPA add-on amounts for certain drugs. Under the CY 2027 ESRD PPS final rule, CMS incorporates phosphate binders, oral-only drugs added to the ESRD PPS in 2025, into the base rate beginning January 1, 2027. Facilities should confirm billing instructions for phosphate binders and other TDAPA drugs for each date of service.

Oral Drugs

When facilities furnish oral ESRD-related drugs, such as phosphate binders and calcimimetics, they must document dispensing and patient education, and coordinate with pharmacies to avoid duplicate billing to Part D.

Laboratory Tests

ESRD-related laboratory tests are included in the bundle and billed by the facility. Facilities must ensure that outside laboratories bill the facility, not Medicare, for ESRD-related tests. Laboratory tests unrelated to ESRD may be billed separately by the laboratory with the AY modifier when documentation supports that they are unrelated.

Consolidated Billing and the AY Modifier

The AY modifier indicates that an item or service is not related to the treatment of ESRD and may be paid separately. Misuse of the AY modifier, such as billing ESRD-related drugs or labs separately, results in duplicate payments. Facilities and outside providers should coordinate, and documentation should support the unrelated determination when the AY modifier is used.

Comorbidity Documentation

Comorbidity payment adjustments apply only when qualifying conditions are documented with appropriate diagnostic evidence within specified time frames. Facilities should obtain physician documentation and diagnostic results that support each comorbidity code billed.

Monthly Physician Notes

OIG cited medical records lacking monthly progress notes from a physician or other qualified professional. Facilities should coordinate with nephrology practices to ensure that monthly progress notes, which also support the physician's monthly capitation payment, are documented and available in the facility record.

Building a Documentation Audit Program

Monthly Audits

• Select a sample of patients each month.

• Verify orders and prescriptions for each treatment.

• Review flow sheets for completeness.

• Verify drug administration against orders and claims.

• Verify height and weight reporting.

• Verify comorbidity documentation.

• Verify monthly physician notes.

Drug Reconciliation

• Reconcile drug inventory, administration records, and claim units monthly.

• Investigate variances.

Home Dialysis Audits

• Review home treatment logs, dispensing records, training documentation, and monthly assessments.

Education

• Train nurses and technicians on flow sheet documentation and drug administration records.

• Train billing staff on ESA monitoring, TDAPA, and AY modifier rules.

Corrective Action

• Correct errors, rebill or refund as required, and return overpayments within 60 days.

Responding to Medical Review

• Calendar deadlines, generally 45 days for MAC additional documentation requests.

• Provide orders, prescriptions, flow sheets, drug administration records, lab results, assessments, plans of care, and physician notes for each claim.

• Include a cover letter summarizing how each claim meets requirements.

• Appeal unfavorable determinations under 42 CFR Part 405, Subpart I, submitting all evidence by the reconsideration level.

A Hypothetical Example

A dialysis facility's drug reconciliation finds that ESA units billed exceeded units administered for several patients because the billing system pulled ordered doses rather than administered doses. The facility corrects the interface, recalculates affected claims, refunds the overpayments, and adds monthly reconciliation. It also reviews home dialysis dispensing records and finds missing documentation of patient receipt, which it corrects with a signed receipt process.

Hospital-Based Dialysis Facilities

Hospital-based ESRD facilities face additional complexity because they share systems with the hospital. Common issues include hospital laboratories billing ESRD-related tests separately instead of through the dialysis facility, pharmacy charges not linked correctly to dialysis claims, and inpatient dialysis furnished during hospital stays being billed incorrectly. Hospital-based facilities should map charge codes carefully, coordinate with hospital departments, and audit claims to ensure ESRD-related services are billed on the ESRD claim.

Acute Kidney Injury Dialysis

Medicare pays for outpatient dialysis furnished to beneficiaries with acute kidney injury at a separate rate, equal to the ESRD PPS base rate in 2026 and adjusted by the wage index. AKI dialysis claims have their own billing requirements, and the patient-level adjustments of the ESRD PPS do not apply. Documentation should identify the AKI diagnosis, the physician's orders, and the treatments furnished. Facilities should not bill AKI patients under ESRD codes or vice versa.

Transplant and Modality Changes

When patients change modality, such as moving from in-center hemodialysis to home peritoneal dialysis, or receive a transplant, documentation must show the dates and orders for each change. Billing errors often occur during transitions, such as continuing to bill in-center treatments after a patient starts home dialysis, or failing to bill training sessions properly. Facilities should update orders, plans of care, and billing records promptly when modality changes.

Medicare Secondary Payer and Coordination Periods

Patients with employer group health plan coverage are subject to a 30-month coordination period during which the employer plan pays first. Facilities must identify these patients and bill the correct primary payer. Billing Medicare as primary during the coordination period creates overpayments that contractors recover. Facilities should verify coverage at admission and periodically, and document the dates of entitlement and coordination.

Patient Education and Rights

The conditions for coverage require facilities to inform patients about their rights, treatment modalities, and transplantation options. Documentation of patient education, including home dialysis and transplant education, supports compliance and is reviewed during surveys. While these requirements may not affect payment directly, OIG's approach of linking conditions for coverage to claim compliance means facilities should document them carefully.

Common Myths About ESRD Documentation

Myth: Standing Protocols Do Not Need Physician Review

Standing orders and protocols must be signed, dated, and periodically reviewed by the physician.

Myth: Ordered Doses Can Be Billed

Only doses actually administered should be reported on claims.

Myth: The AY Modifier Is a Workaround

The AY modifier is only for items and services unrelated to ESRD, supported by documentation.

Myth: Home Patients Need Less Documentation

Home patients require documentation of training, home treatment logs, dispensed drugs and supplies, and monthly assessments.

Questions Leadership Should Ask

• Are dialysis prescriptions and drug orders current and signed for every patient?

• Do flow sheets document every billed treatment?

• Are drug units on claims reconciled with administration records?

• Is medical justification documented for additional treatments?

• Are ESRD-related labs billed by the facility?

• Are home dialysis dispensing records complete?

Key Takeaways

• Orders and prescriptions must support every treatment and drug.

• Flow sheets must document each treatment completely.

• Additional treatments require medical justification.

• Drug billing must reflect administered doses and follow ESA monitoring, TDAPA, and phosphate binder rules.

• Consolidated billing and the AY modifier must be applied correctly.

Laboratory Values and Claims Reporting

ESRD claims require reporting of certain clinical values, such as hemoglobin or hematocrit for ESA claims monitoring and Kt/V or other adequacy measures in some circumstances. These values must match the laboratory results in the record and be reported from the correct time period. Errors in reported values can trigger incorrect application of ESA monitoring modifiers and affect quality reporting. Facilities should validate that lab interfaces populate claims correctly and audit a sample of claims against lab results.

Vascular Access Documentation

Vascular access is central to dialysis care. Documentation should describe the access type, such as fistula, graft, or catheter, its assessment at each treatment, complications, and interventions. Vascular access type is also reported for quality purposes. When patients are referred for access procedures, coordination with surgeons and interventional providers should be documented, and those providers bill their own services separately.

Supplies and Equipment

Dialysis supplies and equipment, including home dialysis machines and supplies, are included in the ESRD PPS bundle. Facilities must ensure that suppliers do not bill Medicare separately for these items and that home patients receive appropriate supplies. Supply documentation for home patients, such as shipment records and patient acknowledgments, supports claims and demonstrates that services were furnished.

Medical Necessity Beyond Dialysis

Although dialysis itself is clearly necessary for ESRD patients, specific drugs, tests, and additional treatments must be medically necessary. For example, ESA doses should reflect individualized hemoglobin targets, iron should be based on iron studies, and additional laboratory tests beyond routine monitoring should have documented reasons. Medical directors and attending nephrologists should review protocols periodically to ensure they reflect current clinical evidence and FDA labeling.

Training Staff on Documentation

Nurses and patient care technicians document most treatment information. Training should cover flow sheet completion, documentation of shortened treatments and complications, drug administration records, weight measurement procedures, and correction of documentation errors using proper late entry procedures. Annual competency reviews and periodic spot checks reinforce these practices.

Electronic Health Record Considerations

Many dialysis organizations use specialized electronic health records that capture machine data automatically. Facilities should validate that automated data, such as treatment times and parameters, are accurate, that staff confirm automated entries, and that systems prevent billing for treatments that were not completed. Audit trails should be retained to show when entries were made and by whom.

Responding to Drug-Related Findings

When auditors question drug billing, facilities should provide orders, administration records with dose and time, lab results supporting dosing decisions, and protocols in effect. For home patients, include dispensing records and patient acknowledgments. If records show billing errors, such as units billed exceeding units administered, acknowledge the errors, correct the claims, and explain the corrective actions taken. Facilities should also review whether the errors affected outlier payments and correct those amounts.

Periodic Protocol Review

Drug protocols for anemia management, iron, and mineral metabolism should be reviewed at least annually by the medical director and quality committee. Reviews should consider changes in FDA labeling, clinical guidelines, and Medicare payment rules, such as the incorporation of phosphate binders into the base rate. Documented protocol reviews show that drug use reflects current standards and supports medical necessity.

Corrections and Late Entries

When documentation errors are discovered, staff should correct them according to policy, using dated and signed late entries or addenda that identify the reason for the correction. Records should never be altered to support billing after an audit request. Auditors may review audit trails, and improper alterations can turn a documentation error into a much more serious compliance problem.

Measuring Documentation Quality

Track documentation metrics each month, such as the percentage of complete flow sheets, timely assessments and plans of care, drug reconciliation variances, and physician note availability. Share results with facility leadership and the medical director, and set improvement targets. Trends help leaders identify units or shifts that need additional training before auditors find the same problems.

Working With Nephrology Practices

Facility documentation depends on physician orders and notes. Facilities should agree with nephrology practices on order signature timelines, protocol review schedules, and how monthly notes will be shared. Regular joint meetings to review audit results help both parties improve.

Documenting Patient Refusals and Missed Treatments

Patients sometimes refuse treatments, leave early, or miss sessions. Documentation should record the event, the reason given, education provided about risks, physician notification, and the plan to resume treatment. Missed sessions should not be billed. Shortened sessions should follow Medicare billing instructions. Consistent documentation of these events protects patients and supports accurate claims.

Retaining Records

Under the conditions for coverage, facilities must retain medical records for the period required by state law, or at least six years from the date of discharge or death, and must make records available to authorized reviewers. Organized, retrievable records make audits faster and reduce findings based on missing documentation.

Frequently Asked Questions

What must a dialysis treatment record include?

Date, start and end times, weights, vital signs, machine settings, monitoring, drugs administered, complications, reasons for shortened treatments, and staff signatures.

When can facilities bill more than three treatments per week?

When additional treatments are medically justified and documented.

What is the AY modifier?

A modifier indicating that an item or service is not related to ESRD and may be paid separately.

How are phosphate binders paid in 2027?

CMS incorporated phosphate binders into the ESRD PPS base rate beginning January 1, 2027.

Why does height and weight documentation matter?

It affects body surface area and body mass index payment adjustments.

Conclusion

ESRD audits focus on whether every treatment, drug, and adjustment is supported by orders and documentation. Facilities that maintain complete prescriptions and orders, thorough flow sheets, accurate drug records, correct height and weight reporting, proper consolidated billing, and monthly physician notes, and that audit regularly, will be well prepared for medical review.

How HealthBridge Can Help

HealthBridge is a healthcare management consulting firm that helps dialysis facilities audit orders, treatment records, and drug billing, reconcile drug inventory, review home dialysis documentation, train staff, and respond to medical review. If your facility wants to strengthen documentation, please get in touch with us. We will be happy to help you with this topic.

References

• U.S. Department of Health and Human Services, Office of Inspector General. Medicare Dialysis Services Provider Compliance Audit: Dialysis Clinic, Inc. (A-05-20-00010). https://oig.hhs.gov/oas/reports/region5/52000010.asp

• U.S. Department of Health and Human Services, Office of Inspector General. Work Plan: Medicare Part B Audit of Home Dialysis Services (A-05-24-00006). https://www.oig.hhs.gov/reports-and-publications/workplan/summary/wp-summary-0000826.asp

• Centers for Medicare & Medicaid Services. Medicare Benefit Policy Manual, Chapter 11, End Stage Renal Disease. https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/bp102c11.pdf

• Centers for Medicare & Medicaid Services. Medicare Claims Processing Manual, Chapter 8, Outpatient ESRD Hospital, Independent Facility, and Physician/Supplier Claims. https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/clm104c08.pdf

• Centers for Medicare & Medicaid Services. MLN Matters MM14313, ESRD and Acute Kidney Injury Dialysis: CY 2026 Update. https://www.cms.gov/files/document/mm14313-esrd-acute-kidney-injury-dialysis-cy-2026-update.pdf

• Centers for Medicare & Medicaid Services. Calendar Year 2027 ESRD Prospective Payment System Final Rule Fact Sheet (CMS-1846-F). https://www.cms.gov/newsroom/fact-sheets/calendar-year-cy-2027-end-stage-renal-disease-esrd-prospective-payment-system-final-rule-cms-1846-f

• Electronic Code of Federal Regulations. 42 CFR Part 413, Subpart H, Payment for End-Stage Renal Disease Services. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-413/subpart-H

• Electronic Code of Federal Regulations. 42 CFR 413.234, Drug Designation Process. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-413/subpart-H/section-413.234

• Electronic Code of Federal Regulations. 42 CFR Part 494, Conditions for Coverage for End-Stage Renal Disease Facilities. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-G/part-494

• Electronic Code of Federal Regulations. 42 CFR Part 405, Subpart I, Determinations, Redeterminations, Reconsiderations, and Appeals Under Original Medicare. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-405/subpart-I

• Electronic Code of Federal Regulations. 42 CFR 401.305, Requirements for Reporting and Returning of Overpayments. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-A/part-401/subpart-D/section-401.305


Some or all of the services described herein may not be permissible for HealthBridge US clients and their affiliates or related entities.

The information provided is general in nature and is not intended to address the specific circumstances of any individual or entity. While we strive to offer accurate and timely information, we cannot guarantee that such information remains accurate after it is received or that it will continue to be accurate over time. Anyone seeking to act on such information should first seek professional advice tailored to their specific situation. HealthBridge US does not offer legal services.

HealthBridge US is not affiliated with any department of public health agencies in any state, nor with the Centers for Medicare & Medicaid Services (CMS). We offer healthcare consulting services exclusively and are an independent consulting firm not affiliated with any regulatory organizations, including but not limited to the Accrediting Organizations, the Centers for Medicare & Medicaid Services (CMS), and state departments. HealthBridge is an anti-fraud company in full compliance with all applicable federal and state regulations for CMS, as well as other relevant business and healthcare laws. The badges, icons, and achievement graphics displayed on this website represent proprietary performance metrics, volume milestones, and internal corporate recognition issued exclusively by our corporate affiliate network at SummitRidge. These visual markers are utilized solely as historical indicators of enterprise growth, operational longevity, and volume-based milestones cleared within our shared corporate ecosystem.

© 2026 HealthBridge US, a California corporation. All rights reserved.

For more information about the structure of HealthBridge, visit www.myhbconsulting.com/governance

Legal

Resources